Do obese women benefit less from adjuvant endocrine therapy with aromatase inhibitors? Preliminary analysis on the association of BMI and aromatase inhibitor plasma levels.
D. Egle
No relevant relationships to disclose
A. Oberguggenberger
No relevant relationships to disclose
R. Achleitner
No relevant relationships to disclose
M. Sztankay
No relevant relationships to disclose
V. Meraner
No relevant relationships to disclose
J. Giesinger
No relevant relationships to disclose
B. Sperner-Unterweger
No relevant relationships to disclose
B. Holzner
No relevant relationships to disclose
B. Beer
No relevant relationships to disclose
H. Oberacher
No relevant relationships to disclose
C. Marth
No relevant relationships to disclose
M. Hubalek
No relevant relationships to disclose